Agilon Health (NYSE:AGL) Stock Price Up 3.3% – What’s Next?

Agilon Health, Inc. (NYSE:AGL) shares shot up 3.3% on Thursday . The company traded as high as $97.26 and last traded at $96.6460. 26,568 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 341,372 shares. The stock had previously closed at $93.59.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the stock. Barclays set a $111.00 price target on shares of Agilon Health and gave the stock an “equal weight” rating in a research note on Thursday, August 6th. Robert W. Baird set a $116.00 price objective on Agilon Health in a research note on Thursday, August 6th. Citigroup raised Agilon Health from a “sell” rating to a “neutral” rating and increased their price objective for the company from $105.00 to $115.00 in a report on Monday, August 10th. Truist Financial set a $112.00 target price on Agilon Health and gave the stock a “hold” rating in a research report on Thursday, August 6th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $146.00 target price (up from $141.00) on shares of Agilon Health in a research note on Tuesday, August 11th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Agilon Health has a consensus rating of “Hold” and an average price target of $97.70.

Agilon Health Stock Performance

The stock has a market capitalization of $1.50 billion, a PE ratio of -6.28 and a beta of 3.02. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08. The business’s fifty day moving average price is $99.78 and its 200-day moving average price is $69.08.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. The company had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. As a group, equities research analysts expect that Agilon Health, Inc. will post -2.11 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in AGL. Allworth Financial LP purchased a new stake in shares of Agilon Health in the second quarter worth $114,000. Proficio Capital Partners LLC purchased a new position in Agilon Health during the second quarter worth about $210,000. Bank of New York Mellon Corp grew its position in Agilon Health by 9.5% during the second quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company’s stock worth $3,787,000 after buying an additional 3,074 shares in the last quarter. The Manufacturers Life Insurance Company bought a new position in Agilon Health in the 2nd quarter worth about $355,000. Finally, Integrated Wealth Concepts LLC bought a new position in Agilon Health in the 2nd quarter worth about $384,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.